封面
市场调查报告书
商品编码
1827779

2025年自我监测血糖(SMBG)全球市场报告

Self-Monitoring Blood Glucose (SMBG) Devices Global Market Report 2025

出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来,自我血糖监测 (SMBG) 市场规模强劲成长,从 2024 年的 152.3 亿美元成长至 2025 年的 161.9 亿美元,复合年增长率为 6.3%。预测期内的成长可归因于糖尿病盛行率上升、医疗保健意识增强、人口老化、政府措施和法规以及医疗保健支出的增加。

预计未来几年自我血糖监测 (SMBG) 市场将强劲成长,到 2029 年将达到 223.5 亿美元,复合年增长率为 8.4%。预测期内的成长归因于家庭医疗保健的兴起、远端医疗的扩展、可支配收入的提高、远端监测需求的增加以及电子商务的兴起。预测期内的主要趋势包括持续血糖监测 (CGM) 整合、人工智慧 (AI) 和机器学习、穿戴式 SMBG 设备、非侵入式监测、行动应用程式和连接性。

自我血糖监测 (SMBG) 设备是一种可携式仪器,旨在识别潜在的糖尿病指标。这些设备通常透过刺破患者手指抽取少量血液来评估血糖浓度。国际指引推荐使用这种方法来有效管理患者的糖尿病。 SMBG 设备有助于测量血糖值。

自我血糖监测仪 (SMBG) 的主要类型包括自我监测仪、连续血糖监测仪、试纸和采血针。自我监测仪是患者在家中用来监测血糖值的手持装置。这些设备通常需要精确滴血。它们可在医院药房、零售药房、线上零售商以及糖尿病诊所和中心购买。这些设备适用于各种情况,包括第 1 型糖尿病、2 型糖尿病和妊娠糖尿病。

2025年春季,美国关税突然上调及其引发的贸易摩擦对用于诊断影像设备的进口零件、手术用不銹钢和一次性塑胶製品产生了重大影响。由于医院和诊所抵制涨价,製造商面临利润压力。监管挑战使情况更加复杂,因为由于关税而更换供应商通常需要重新认证医疗设备,导致市场进入延迟。为此,企业正在透过双重采购关键零件、增加标准化产品的国内生产以及加快寻找更具成本效益的材料来降低风险。

本研究报告是商业研究公司 (The Business Research Company) 新报告系列的一部分,该系列提供自我血糖监测 (SMBG) 市场统计数据,例如全球市场规模、区域份额、竞争对手的市场份额、详细的自我血糖监测 (SMBG) 细分市场、市场趋势和机会,以及您在自我血糖监测 (SMBG) 行业取得成功所需的数据。本自我血糖监测 (SMBG) 市场研究报告对该行业的现状和未来情况进行了详细分析,为您提供所需的一切观点。

未来五年8.4%的预测成长率,较我们先前对该市场的预测略有下降0.3%。这一下降主要源自于美国与其他国家之间关税的影响。这种影响可能会直接影响美国,具体表现为对主要从中国和墨西哥进口的葡萄糖氧化酵素试纸和微型采血针针筒征收更高的关税,从而推高糖尿病护理产品的成本。此外,由于互惠关税以及贸易紧张局势和限制加剧对全球经济和贸易的负面影响,这种影响也将更加广泛。

糖尿病盛行率的上升预计将在未来几年推动自我监测设备市场的成长。自我监测是指糖尿病患者使用血糖值监测设备(例如血糖仪)测量血糖值。这使他们能够调整或监测治疗方法(饮食、运动、胰岛素、抗糖尿病药物)的有效性,并根据测试结果咨询医生。例如,2024 年 3 月,英国政府部门健康改善与差异办公室报告称,在 2022 年 3 月至 2023 年 3 月期间,接受所有八个建议护理步骤的 1 型糖尿病患者比例增加了 22%。对于第 2 型糖尿病,这一数字增加了 21%,HbA1c 目标达成率达到 37.9%,创下美国国家糖尿病审核(NDA) 记录的最高水准。因此,糖尿病盛行率的上升正在推动自我监测设备市场的成长。

推动自我血糖监测市场成长的另一个因素是老年人口的不断成长。老年人口通常为65岁及以上,他们会经历与老龄化相关的生理和认知变化,因此有效的糖尿病管理至关重要。自我血糖监测在帮助老年人管理糖尿病方面发挥关键作用,因为它可以帮助他们及时调整药物和生活方式。根据世界卫生组织(WHO)2022年10月的报告,预计到2050年,全球60岁以上人口将达到21亿,满足老年人的医疗保健需求显得尤为重要。因此,不断增长的老年人口正在推动自我血糖监测市场的扩张。

技术进步是血糖监测设备市场的一大趋势。该市场的主要企业正在积极开发尖端产品,以提升其市场占有率。例如,专注于血糖监测设备的美国公司 Know Labs Inc. 推出了采用生物射频辨识 (Bio-RFID) 技术的医疗级可携式血糖监测设备 KnowU。这款非侵入式设备为传统侵入式血糖监测设备提供了经济实惠且便利的替代方案,为使用者提供随时随地的监测功能。

自我血糖监测设备市场的主要企业正日益关注基于感测器的血糖监测设备,以期获得竞争优势。这些医疗工具可以持续或间歇地测量和报告血糖值,帮助糖尿病患者有效管理病情。 2022年9月,雅培实验室的FreeStyle Libre 2和FreeStyle Libre 3感测器获得美国食品药物管理局(FDA)核准,可与自动胰岛素输送系统(AID)整合。此次核准标誌着基于感测器即时血糖数据自动调整胰岛素剂量,从而增强糖尿病治疗效果的重要一步。

2022年9月,法国血糖值监测产品製造商Biocorp与诺和诺德合作。此次合作旨在开发和销售诺和诺德Flex Touch智慧触控笔的附加元件设备“Maruya”,该设备专为医疗设备患者设计。 Biocorp和诺和诺德坚信,​​此次合作将协助他们为糖尿病患者提供最佳解决方案。诺和诺德是一家总部位于丹麦的医疗保健公司。

自我监测血糖 (SMBG) 市场的主要参与者包括雅培实验室 (Abbott Laboratories)、Bionime Corporation、B. Braun Melsungen AG、F. Hoffmann-La Roche Ltd、LifeScan Inc、PHC Holdings Corporation、Home Diagnostics Inc、 Terumo Corporation PharmaceuticalMed Solutions、ARKRAY Inc、Ypsomed. D.S. A/S、Glysens Incorporated、Senseonics Holdings Inc、AgaMatrix Inc、All Medicus Co. Ltd.、Ascensia Diabetes Care Holdings AG、拜耳公司 (Bayer AG)、Becton Dickinson and Company、Bio-Rad Laboratories Inc.、Bioptik Technology Inc.、CnoCare Medical Ltd. Corporation、Integrity Applications、强生公司 (Johnson & Johnson & Johnson)、Menarini Diagnostics、Nemaura Medical Inc.、Nipro Corporation、Nova Biomedical Corporation、Omron Healthcare Inc.、Optiscan Biomedical Corporation、OrSense Ltd.、Pinnacle Technology Inc.、Prodigy Diabetes LLC LLC.

2024年,北美是自我血糖监测 (SMBG) 市场最大的地区。预计欧洲将成为预测期内成长最快的地区。本自我血糖监测 (SMBG) 市场分析报告涵盖亚太地区、西欧、中欧和东欧、北美、南美以及中东和非洲。

自我血糖监测 (SMBG) 市场报告涵盖澳洲、巴西、中国、法国、德国、印度、印尼、日本、俄罗斯、韩国、英国和美国。

自我血糖监测 (SMBG) 设备市场由设备和仪器的销售组成。该市场的价值是“出厂价”,即产品製造商或生产商销售给其他营业单位(包括下游製造商、批发商、经销商和零售商)或直接销售给最终客户的价值。该市场的产品价值还包括产品製造商销售的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场:宏观经济情景,包括利率、通膨、地缘政治、贸易战和关税,以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球自我血糖监测设备 (SMBG):PESTEL 分析(政治、社会、技术、环境、法律因素、驱动因素和限制因素)
  • 最终用途产业分析
  • 全球自我监测血糖(SMBG)市场:成长率分析
  • 全球自我监测血糖 (SMBG) 市场表现:规模与成长,2019-2024 年
  • 全球自我监测血糖 (SMBG) 市场预测:规模与成长,2024-2029 年,2034 年预测
  • 全球自我监测血糖 (SMBG) 设备:总目标市场 (TAM)

第六章 市场细分

  • 全球自我血糖监测 (SMBG) 市场:依产品、绩效及预测,2019-2024 年、2024-2029 年、2034 年
  • 自我血糖仪
  • 连续血糖监测仪
  • 测试条
  • 《采血针》
  • 全球自我血糖监测 (SMBG) 市场:依通路、实际及预测,2019-2024 年、2024-2029 年、2034 年
  • 医院药房
  • 零售药局
  • 网上销售
  • 糖尿病诊所和中心
  • 全球自我血糖监测 (SMBG) 市场:按应用、效能和预测,2019-2024 年、2024-2029 年、2034 年
  • 1型糖尿病
  • 2型糖尿病
  • 妊娠糖尿病
  • 全球自我血糖监测 (SMBG) 市场:按类型、实际和预测细分,2019-2024 年、2024-2029 年、2034 年
  • 传统血糖监测仪
  • 智慧型血糖仪
  • 全球自我血糖监测 (SMBG) 市场:按连续血糖监测 (CGM) 细分,类型、性能和预测,2019-2024 年、2024-2029 年、2034 年
  • 即时CGM
  • Flash血糖监测系统
  • 全球自我血糖监测 (SMBG) 市场:试纸细分(按类型)、实际和预测,2019-2024 年、2024-2029 年、2034 年
  • 标准测试条
  • 特定仪表的测试条
  • 全球自我血糖监测 (SMBG) 市场:按柳叶刀采血针(按类型)、实际和预测,2019-2024 年、2024-2029 年、2034 年
  • 标准采血针
  • 安全采血针

第七章 区域和国家分析

  • 全球自我血糖监测 (SMBG) 市场:按地区、绩效及预测,2019-2024 年、2024-2029 年、2034 年
  • 全球自我血糖监测 (SMBG) 市场:按国家/地区、绩效及预测,2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章:中国市场

第十章 印度市场

第十一章 日本市场

第十二章:澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章:西欧市场

第十六章英国市场

第十七章:德国市场

第18章:法国市场

第十九章:义大利市场

第20章:西班牙市场

第21章 东欧市场

第22章:俄罗斯市场

第23章 北美市场

第24章美国市场

第25章:加拿大市场

第26章 南美洲市场

第27章:巴西市场

第28章 中东市场

第29章:非洲市场

第30章:竞争格局与公司概况

  • 自我血糖监测设备(SMBG)市场:竞争格局
  • 自我血糖监测(SMBG)市场:公司简介
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Bionime Corporation Overview, Products and Services, Strategy and Financial Analysis
    • B. Braun Melsungen AG Overview, Products and Services, Strategy and Financial Analysis
    • F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
    • LifeScan Inc Overview, Products and Services, Strategy and Financial Analysis

第31章:其他领先和创新企业

  • PHC Holdings Corporation
  • Home Diagnostics Inc
  • Terumo Pharmaceutical Solutions
  • ARKRAY Inc
  • Ypsomed Holding AG
  • Dexcom Inc
  • Medtronic plc
  • Novo Nordisk A/S
  • Glysens Incorporated
  • Senseonics Holdings Inc.
  • AgaMatrix Inc.
  • All Medicus Co. Ltd.
  • Ascensia Diabetes Care Holdings AG
  • Bayer AG
  • Becton Dickinson and Company

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章:高潜力市场国家、细分市场与策略

  • 2029年自我血糖监测(SMBG)市场:提供新机会的国家
  • 2029年自我血糖监测(SMBG)市场:细分市场带来新机会
  • 2029年自我血糖监测(SMBG)市场:成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r22066u

A Self-Monitoring Blood Glucose (SMBG) device is a portable instrument designed to identify potential diabetes indicators. Typically, these devices assess glucose levels by extracting a small blood drop from patients through a finger prick. International guidelines recommend this method for effectively managing diabetes in patients. SMBG devices are instrumental in measuring the concentration of glucose in the blood.

The primary types of Self-Monitoring Blood Glucose (SMBG) devices include self-monitoring blood glucose meters, continuous glucose monitors, testing strips, and lancets. Self-monitoring blood glucose meters are handheld devices utilized by patients at home to monitor their blood glucose levels. These meters typically require a blood drop obtained through a pinprick. They are distributed through hospital pharmacies, retail pharmacies, online sales, and diabetes clinics and centers. These devices find application in various contexts such as Type 1 Diabetes, Type 2 Diabetes, and Gestational Diabetes.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The self-monitoring blood glucose (SMBG) devices market research report is one of a series of new reports from The Business Research Company that provides self-monitoring blood glucose (SMBG) devices market statistics, including self-monitoring blood glucose (SMBG) devices industry global market size, regional shares, competitors with a self-monitoring blood glucose (SMBG) devices market share, detailed self-monitoring blood glucose (SMBG) devices market segments, market trends and opportunities, and any further data you may need to thrive in the self-monitoring blood glucose (SMBG) devices industry. This self-monitoring blood glucose (SMBG) devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The self-monitoring blood glucose (smbg) devices market size has grown strongly in recent years. It will grow from $15.23 billion in 2024 to $16.19 billion in 2025 at a compound annual growth rate (CAGR) of 6.3%. The growth in the historic period can be attributed to rise in prevalence of diabetes, increase in healthcare awareness, aging population, government initiatives and regulations, rise in healthcare spending.

The self-monitoring blood glucose (smbg) devices market size is expected to see strong growth in the next few years. It will grow to $22.35 billion in 2029 at a compound annual growth rate (CAGR) of 8.4%. The growth in the forecast period can be attributed to rising home healthcare, telehealth expansion, rise in disposable income, rising demand for remote monitoring, rise in e-commerce. Major trends in the forecast period include continuous glucose monitoring (CGM) integration, artificial intelligence (AI) and machine learning, wearable smbg devices, non-invasive monitoring, mobile apps and connectivity.

The forecast of 8.4% growth over the next five years reflects a modest reduction of 0.3% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through increased tariffs on glucose oxidase test strips and miniature lancet drums, mainly imported from China and Mexico, raising costs for diabetes care products.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing prevalence of diabetes is anticipated to drive the growth of the self-monitoring blood glucose device market in the coming years. Self-monitoring of blood glucose involves individuals with diabetes using a glycemic reading device, such as a glucose meter, to measure their blood sugar levels. This allows them to adjust or monitor the effectiveness of their treatment options (diet, exercise, insulin, antidiabetics) or consult their physician based on the test results. For example, in March 2024, the Office for Health Improvement & Disparities, a UK government department, reported that between March 2022 and March 2023, the proportion of individuals with type 1 diabetes receiving all eight recommended care processes rose by 22%. For type 2 diabetes, this figure increased by 21%, with the percentage achieving target HbA1c levels reaching 37.9%, the highest ever recorded by the National Diabetes Audit (NDA). As a result, the rising prevalence of diabetes is fueling the growth of the self-monitoring blood glucose device market.

Another contributing factor to the growth of the self-monitoring blood glucose devices market is the rising geriatric population. This demographic, typically aged 65 and older, experiences age-related physical and cognitive changes, making effective diabetes management crucial. Self-monitoring blood glucose devices play a vital role in helping elderly individuals manage diabetes by facilitating timely adjustments to medication and lifestyle choices. As per the World Health Organization's October 2022 report, the global population aged 60 or older is expected to reach 2.1 billion by 2050, highlighting the increasing significance of catering to the healthcare needs of the elderly. Consequently, the growing geriatric population is a driving force behind the expansion of the self-monitoring blood glucose devices market.

A prominent trend in the self-monitoring blood glucose devices market is technological advancement. Leading companies in this market are actively engaged in developing cutting-edge products to enhance their market presence. For example, Know Labs Inc., a US-based company specializing in glucose monitoring devices, introduced the KnowU, a portable medical-grade glucose monitoring device leveraging Bio-RFID technology. This non-invasive device offers an affordable and convenient alternative to traditional, more invasive blood glucose monitoring devices, providing users with on-the-go monitoring capabilities.

The major players in the self-monitoring blood glucose devices market are increasingly focusing on sensor-based glucose monitoring devices to gain a competitive edge. These medical tools continuously or intermittently measure and report blood glucose levels, aiding individuals with diabetes in managing their condition effectively. In September 2022, Abbott Laboratories received approval from the USFDA for FreeStyle Libre 2 and FreeStyle Libre 3 sensors, allowing integration with Automated Insulin Delivery Systems (AIDs). This approval signifies a significant step toward enhancing diabetes care by automating insulin adjustments based on real-time glucose data from the sensors.

In September 2022, Biocorp, a French manufacturer of medical devices, including blood glucose monitoring products, formed a partnership with Novo Nordisk. This collaboration was announced for the development and distribution of the Mallya smart add-on device for Novo Nordisk's FlexTouch pen, designed for individuals with diabetes. Both Biocorp and Novo Nordisk believe that this partnership will enable them to offer optimal solutions for people living with diabetes. Novo Nordisk is a healthcare company based in Denmark.

Major companies operating in the self-monitoring blood glucose (SMBG) devices market include Abbott Laboratories, Bionime Corporation, B. Braun Melsungen AG, F. Hoffmann-La Roche Ltd, LifeScan Inc, PHC Holdings Corporation, Home Diagnostics Inc, Terumo Pharmaceutical Solutions, ARKRAY Inc, Ypsomed Holding AG, Dexcom Inc, Medtronic plc, Novo Nordisk A/S, Glysens Incorporated, Senseonics Holdings Inc., AgaMatrix Inc., All Medicus Co. Ltd., Ascensia Diabetes Care Holdings AG, Bayer AG, Becton Dickinson and Company, Bio-Rad Laboratories Inc., Bioptik Technology Inc., Cnoga Medical Ltd., ForaCare Inc., Glucovation Inc., Hainice Medical Inc., Infopia Co. Ltd., Insulet Corporation, Integrity Applications, Johnson & Johnson, Menarini Diagnostics, Nemaura Medical Inc., Nipro Corporation, Nova Biomedical Corporation, Omron Healthcare Inc., Optiscan Biomedical Corporation, OrSense Ltd., Pinnacle Technology Inc., Prodigy Diabetes Care LLC, PTS Diagnostics, TaiDoc Technology Corporation, Trividia Health Inc., WaveForm Technologies Inc.

North America was the largest region in the self-monitoring blood glucose (SMBG) devices market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in this self-monitoring blood glucose (SMBG) devices market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the self-monitoring blood glucose (SMBG) devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The self-monitoring blood glucose (SMBG) device market consists of sales of devices and instruments. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Self-Monitoring Blood Glucose (SMBG) Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on self-monitoring blood glucose (smbg) devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for self-monitoring blood glucose (smbg) devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The self-monitoring blood glucose (smbg) devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Self-Monitoring Blood Glucose Meters; Continuous Glucose Monitors; Testing Strips; Lancets
  • 2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Sales; Diabetes Clinics & Centers
  • 3) By Application: Type 1 Diabetes; Type 2 Diabetes; Gestational Diabetes
  • Subsegments:
  • 1) By Self-Monitoring Blood Glucose Meters: Traditional Glucose Meters; Smart Glucose Meters
  • 2) By Continuous Glucose Monitors (CGMs): Real-Time CGMs; Flash Glucose Monitoring Systems
  • 3) By Testing Strips: Standard Testing Strips; Test Strips for Specific Meters
  • 4) By Lancets: Standard Lancets; Safety Lancets
  • Companies Mentioned: Abbott Laboratories; Bionime Corporation; B. Braun Melsungen AG; F. Hoffmann-La Roche Ltd; LifeScan Inc; PHC Holdings Corporation; Home Diagnostics Inc; Terumo Pharmaceutical Solutions; ARKRAY Inc; Ypsomed Holding AG; Dexcom Inc; Medtronic plc; Novo Nordisk A/S; Glysens Incorporated; Senseonics Holdings Inc.; AgaMatrix Inc.; All Medicus Co. Ltd.; Ascensia Diabetes Care Holdings AG; Bayer AG; Becton Dickinson and Company; Bio-Rad Laboratories Inc.; Bioptik Technology Inc.; Cnoga Medical Ltd.; ForaCare Inc.; Glucovation Inc.; Hainice Medical Inc.; Infopia Co. Ltd.; Insulet Corporation; Integrity Applications; Johnson & Johnson; Menarini Diagnostics; Nemaura Medical Inc.; Nipro Corporation; Nova Biomedical Corporation; Omron Healthcare Inc.; Optiscan Biomedical Corporation; OrSense Ltd.; Pinnacle Technology Inc.; Prodigy Diabetes Care LLC; PTS Diagnostics; TaiDoc Technology Corporation; Trividia Health Inc.; WaveForm Technologies Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Self-Monitoring Blood Glucose (SMBG) Devices Market Characteristics

3. Self-Monitoring Blood Glucose (SMBG) Devices Market Trends And Strategies

4. Self-Monitoring Blood Glucose (SMBG) Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Self-Monitoring Blood Glucose (SMBG) Devices Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Self-Monitoring Blood Glucose (SMBG) Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Self-Monitoring Blood Glucose (SMBG) Devices Market Growth Rate Analysis
  • 5.4. Global Self-Monitoring Blood Glucose (SMBG) Devices Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Self-Monitoring Blood Glucose (SMBG) Devices Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Self-Monitoring Blood Glucose (SMBG) Devices Total Addressable Market (TAM)

6. Self-Monitoring Blood Glucose (SMBG) Devices Market Segmentation

  • 6.1. Global Self-Monitoring Blood Glucose (SMBG) Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Self-Monitoring Blood Glucose Meters
  • Continuous Glucose Monitors
  • Testing Strips
  • Lancets
  • 6.2. Global Self-Monitoring Blood Glucose (SMBG) Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Sales
  • Diabetes Clinics & Centers
  • 6.3. Global Self-Monitoring Blood Glucose (SMBG) Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Type1 Diabetes
  • Type 2 Diabetes
  • Gestational Diabetes
  • 6.4. Global Self-Monitoring Blood Glucose (SMBG) Devices Market, Sub-Segmentation Of Self-Monitoring Blood Glucose Meters, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Traditional Glucose Meters
  • Smart Glucose Meters
  • 6.5. Global Self-Monitoring Blood Glucose (SMBG) Devices Market, Sub-Segmentation Of Continuous Glucose Monitors (CGMs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Real-Time CGMs
  • Flash Glucose Monitoring Systems
  • 6.6. Global Self-Monitoring Blood Glucose (SMBG) Devices Market, Sub-Segmentation Of Testing Strips, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Standard Testing Strips
  • Test Strips for Specific Meters
  • 6.7. Global Self-Monitoring Blood Glucose (SMBG) Devices Market, Sub-Segmentation Of Lancets, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Standard Lancets
  • Safety Lancets

7. Self-Monitoring Blood Glucose (SMBG) Devices Market Regional And Country Analysis

  • 7.1. Global Self-Monitoring Blood Glucose (SMBG) Devices Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Self-Monitoring Blood Glucose (SMBG) Devices Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Self-Monitoring Blood Glucose (SMBG) Devices Market

  • 8.1. Asia-Pacific Self-Monitoring Blood Glucose (SMBG) Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Self-Monitoring Blood Glucose (SMBG) Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Self-Monitoring Blood Glucose (SMBG) Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Self-Monitoring Blood Glucose (SMBG) Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Self-Monitoring Blood Glucose (SMBG) Devices Market

  • 9.1. China Self-Monitoring Blood Glucose (SMBG) Devices Market Overview
  • 9.2. China Self-Monitoring Blood Glucose (SMBG) Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Self-Monitoring Blood Glucose (SMBG) Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Self-Monitoring Blood Glucose (SMBG) Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Self-Monitoring Blood Glucose (SMBG) Devices Market

  • 10.1. India Self-Monitoring Blood Glucose (SMBG) Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Self-Monitoring Blood Glucose (SMBG) Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Self-Monitoring Blood Glucose (SMBG) Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Self-Monitoring Blood Glucose (SMBG) Devices Market

  • 11.1. Japan Self-Monitoring Blood Glucose (SMBG) Devices Market Overview
  • 11.2. Japan Self-Monitoring Blood Glucose (SMBG) Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Self-Monitoring Blood Glucose (SMBG) Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Self-Monitoring Blood Glucose (SMBG) Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Self-Monitoring Blood Glucose (SMBG) Devices Market

  • 12.1. Australia Self-Monitoring Blood Glucose (SMBG) Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Self-Monitoring Blood Glucose (SMBG) Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Self-Monitoring Blood Glucose (SMBG) Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Self-Monitoring Blood Glucose (SMBG) Devices Market

  • 13.1. Indonesia Self-Monitoring Blood Glucose (SMBG) Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Self-Monitoring Blood Glucose (SMBG) Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Self-Monitoring Blood Glucose (SMBG) Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Self-Monitoring Blood Glucose (SMBG) Devices Market

  • 14.1. South Korea Self-Monitoring Blood Glucose (SMBG) Devices Market Overview
  • 14.2. South Korea Self-Monitoring Blood Glucose (SMBG) Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Self-Monitoring Blood Glucose (SMBG) Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Self-Monitoring Blood Glucose (SMBG) Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Self-Monitoring Blood Glucose (SMBG) Devices Market

  • 15.1. Western Europe Self-Monitoring Blood Glucose (SMBG) Devices Market Overview
  • 15.2. Western Europe Self-Monitoring Blood Glucose (SMBG) Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Self-Monitoring Blood Glucose (SMBG) Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Self-Monitoring Blood Glucose (SMBG) Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Self-Monitoring Blood Glucose (SMBG) Devices Market

  • 16.1. UK Self-Monitoring Blood Glucose (SMBG) Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Self-Monitoring Blood Glucose (SMBG) Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Self-Monitoring Blood Glucose (SMBG) Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Self-Monitoring Blood Glucose (SMBG) Devices Market

  • 17.1. Germany Self-Monitoring Blood Glucose (SMBG) Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Self-Monitoring Blood Glucose (SMBG) Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Self-Monitoring Blood Glucose (SMBG) Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Self-Monitoring Blood Glucose (SMBG) Devices Market

  • 18.1. France Self-Monitoring Blood Glucose (SMBG) Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Self-Monitoring Blood Glucose (SMBG) Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Self-Monitoring Blood Glucose (SMBG) Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Self-Monitoring Blood Glucose (SMBG) Devices Market

  • 19.1. Italy Self-Monitoring Blood Glucose (SMBG) Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Self-Monitoring Blood Glucose (SMBG) Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Self-Monitoring Blood Glucose (SMBG) Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Self-Monitoring Blood Glucose (SMBG) Devices Market

  • 20.1. Spain Self-Monitoring Blood Glucose (SMBG) Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Self-Monitoring Blood Glucose (SMBG) Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Self-Monitoring Blood Glucose (SMBG) Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Self-Monitoring Blood Glucose (SMBG) Devices Market

  • 21.1. Eastern Europe Self-Monitoring Blood Glucose (SMBG) Devices Market Overview
  • 21.2. Eastern Europe Self-Monitoring Blood Glucose (SMBG) Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Self-Monitoring Blood Glucose (SMBG) Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Self-Monitoring Blood Glucose (SMBG) Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Self-Monitoring Blood Glucose (SMBG) Devices Market

  • 22.1. Russia Self-Monitoring Blood Glucose (SMBG) Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Self-Monitoring Blood Glucose (SMBG) Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Self-Monitoring Blood Glucose (SMBG) Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Self-Monitoring Blood Glucose (SMBG) Devices Market

  • 23.1. North America Self-Monitoring Blood Glucose (SMBG) Devices Market Overview
  • 23.2. North America Self-Monitoring Blood Glucose (SMBG) Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Self-Monitoring Blood Glucose (SMBG) Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Self-Monitoring Blood Glucose (SMBG) Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Self-Monitoring Blood Glucose (SMBG) Devices Market

  • 24.1. USA Self-Monitoring Blood Glucose (SMBG) Devices Market Overview
  • 24.2. USA Self-Monitoring Blood Glucose (SMBG) Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Self-Monitoring Blood Glucose (SMBG) Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Self-Monitoring Blood Glucose (SMBG) Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Self-Monitoring Blood Glucose (SMBG) Devices Market

  • 25.1. Canada Self-Monitoring Blood Glucose (SMBG) Devices Market Overview
  • 25.2. Canada Self-Monitoring Blood Glucose (SMBG) Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Self-Monitoring Blood Glucose (SMBG) Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Self-Monitoring Blood Glucose (SMBG) Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Self-Monitoring Blood Glucose (SMBG) Devices Market

  • 26.1. South America Self-Monitoring Blood Glucose (SMBG) Devices Market Overview
  • 26.2. South America Self-Monitoring Blood Glucose (SMBG) Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Self-Monitoring Blood Glucose (SMBG) Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Self-Monitoring Blood Glucose (SMBG) Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Self-Monitoring Blood Glucose (SMBG) Devices Market

  • 27.1. Brazil Self-Monitoring Blood Glucose (SMBG) Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Self-Monitoring Blood Glucose (SMBG) Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Self-Monitoring Blood Glucose (SMBG) Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Self-Monitoring Blood Glucose (SMBG) Devices Market

  • 28.1. Middle East Self-Monitoring Blood Glucose (SMBG) Devices Market Overview
  • 28.2. Middle East Self-Monitoring Blood Glucose (SMBG) Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Self-Monitoring Blood Glucose (SMBG) Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Self-Monitoring Blood Glucose (SMBG) Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Self-Monitoring Blood Glucose (SMBG) Devices Market

  • 29.1. Africa Self-Monitoring Blood Glucose (SMBG) Devices Market Overview
  • 29.2. Africa Self-Monitoring Blood Glucose (SMBG) Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Self-Monitoring Blood Glucose (SMBG) Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Self-Monitoring Blood Glucose (SMBG) Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Self-Monitoring Blood Glucose (SMBG) Devices Market Competitive Landscape And Company Profiles

  • 30.1. Self-Monitoring Blood Glucose (SMBG) Devices Market Competitive Landscape
  • 30.2. Self-Monitoring Blood Glucose (SMBG) Devices Market Company Profiles
    • 30.2.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Bionime Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. B. Braun Melsungen AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. LifeScan Inc Overview, Products and Services, Strategy and Financial Analysis

31. Self-Monitoring Blood Glucose (SMBG) Devices Market Other Major And Innovative Companies

  • 31.1. PHC Holdings Corporation
  • 31.2. Home Diagnostics Inc
  • 31.3. Terumo Pharmaceutical Solutions
  • 31.4. ARKRAY Inc
  • 31.5. Ypsomed Holding AG
  • 31.6. Dexcom Inc
  • 31.7. Medtronic plc
  • 31.8. Novo Nordisk A/S
  • 31.9. Glysens Incorporated
  • 31.10. Senseonics Holdings Inc.
  • 31.11. AgaMatrix Inc.
  • 31.12. All Medicus Co. Ltd.
  • 31.13. Ascensia Diabetes Care Holdings AG
  • 31.14. Bayer AG
  • 31.15. Becton Dickinson and Company

32. Global Self-Monitoring Blood Glucose (SMBG) Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Self-Monitoring Blood Glucose (SMBG) Devices Market

34. Recent Developments In The Self-Monitoring Blood Glucose (SMBG) Devices Market

35. Self-Monitoring Blood Glucose (SMBG) Devices Market High Potential Countries, Segments and Strategies

  • 35.1 Self-Monitoring Blood Glucose (SMBG) Devices Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Self-Monitoring Blood Glucose (SMBG) Devices Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Self-Monitoring Blood Glucose (SMBG) Devices Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer